169 related articles for article (PubMed ID: 38230294)
1. Chemokine Receptor 2 Targeted PET/CT Imaging Distant Metastases in Pancreatic Ductal Adenocarcinoma.
Zhang X; Detering L; Heo GS; Sultan D; Luehmann H; Li L; Somani V; Lesser J; Tao J; Kang LI; Li A; Lahad D; Rho S; Ruzinova MB; DeNardo DG; Dehdashti F; Lim KH; Liu Y
ACS Pharmacol Transl Sci; 2024 Jan; 7(1):285-293. PubMed ID: 38230294
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Comparing the clinical value of baseline [
Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Li X; Huo L
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4036-4050. PubMed ID: 37493664
[TBL] [Abstract][Full Text] [Related]
4. PET-based Imaging of Chemokine Receptor 2 in Experimental and Disease-related Lung Inflammation.
Liu Y; Gunsten SP; Sultan DH; Luehmann HP; Zhao Y; Blackwell TS; Bollermann-Nowlis Z; Pan JH; Byers DE; Atkinson JJ; Kreisel D; Holtzman MJ; Gropler RJ; Combadiere C; Brody SL
Radiology; 2017 Jun; 283(3):758-768. PubMed ID: 28045644
[TBL] [Abstract][Full Text] [Related]
5. Prospective comparison of (4S)-4-(3-
Cheng MF; Huang YY; Ho BY; Kuo TC; Hsin LW; Shiue CY; Kuo HC; Jeng YM; Yen RF; Tien YW
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):810-820. PubMed ID: 30635754
[TBL] [Abstract][Full Text] [Related]
6. Molecular Imaging Visualizes Recruitment of Inflammatory Monocytes and Macrophages to the Injured Heart.
Heo GS; Kopecky B; Sultan D; Ou M; Feng G; Bajpai G; Zhang X; Luehmann H; Detering L; Su Y; Leuschner F; Combadière C; Kreisel D; Gropler RJ; Brody SL; Liu Y; Lavine KJ
Circ Res; 2019 Mar; 124(6):881-890. PubMed ID: 30661445
[TBL] [Abstract][Full Text] [Related]
7. Targeted PET Imaging of Chemokine Receptor 2-Positive Monocytes and Macrophages in the Injured Heart.
Heo GS; Bajpai G; Li W; Luehmann HP; Sultan DH; Dun H; Leuschner F; Brody SL; Gropler RJ; Kreisel D; Lavine KJ; Liu Y
J Nucl Med; 2021 Jan; 62(1):111-114. PubMed ID: 32444372
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Relative Diagnostic Performance of [
Wu J; Wang Y; Liao T; Rao Z; Gong W; Ou L; Chen Y; Zhang C
Front Oncol; 2021; 11():737827. PubMed ID: 34604078
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Evaluation of
Prignon A; Provost C; Alshoukr F; Wendum D; Couvelard A; Barbet J; Forgez P; Talbot JN; Gruaz-Guyon A
Mol Pharm; 2019 Jun; 16(6):2776-2784. PubMed ID: 31013092
[TBL] [Abstract][Full Text] [Related]
10. The Use of PET Imaging for Prognostic Integrin α
Huang CW; Hsieh WC; Hsu ST; Lin YW; Chung YH; Chang WC; Chiu H; Lin YH; Wu CP; Yen TC; Huang FT
Theranostics; 2017; 7(16):4013-4028. PubMed ID: 29109795
[TBL] [Abstract][Full Text] [Related]
11. Comparison of early and late
Hoppner J; van Genabith L; Hielscher T; Heger U; Sperling L; Colbatzky T; Gutjahr E; Lang M; Pausch T; Spektor AM; Glatting FM; Liermann J; Hackert T; Kratochwil C; Giesel FL; Haberkorn U; Röhrich M
Sci Rep; 2023 Oct; 13(1):17848. PubMed ID: 37857656
[TBL] [Abstract][Full Text] [Related]
12. CC Chemokine Receptor 2-Targeting Copper Nanoparticles for Positron Emission Tomography-Guided Delivery of Gemcitabine for Pancreatic Ductal Adenocarcinoma.
Zhang X; Detering L; Sultan D; Luehmann H; Li L; Heo GS; Zhang X; Lou L; Grierson PM; Greco S; Ruzinova M; Laforest R; Dehdashti F; Lim KH; Liu Y
ACS Nano; 2021 Jan; 15(1):1186-1198. PubMed ID: 33406361
[TBL] [Abstract][Full Text] [Related]
13.
Parihar AS; Mittal BR; Kumar R; Shukla J; Bhattacharya A
Thyroid; 2020 Apr; 30(4):557-567. PubMed ID: 31870227
[No Abstract] [Full Text] [Related]
14. Detection of Bone Metastases by
Tian R; Xie Q; Yu F; Du C; Yao X; Zang S; Zhang C; Zhang P; Shao G; Yang Z; Wang F; Yu J
Contrast Media Mol Imaging; 2022; 2022():1750132. PubMed ID: 36447752
[TBL] [Abstract][Full Text] [Related]
15. Head-to-head comparison of [
Ballal S; Yadav MP; Roesch F; Satapathy S; Moon ES; Martin M; Wakade N; Sheokand P; Tripathi M; Chandekar KR; Agarwal S; Sahoo RK; Rastogi S; Bal C
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):233-244. PubMed ID: 37642703
[TBL] [Abstract][Full Text] [Related]
16. Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial.
Brody SL; Gunsten SP; Luehmann HP; Sultan DH; Hoelscher M; Heo GS; Pan J; Koenitzer JR; Lee EC; Huang T; Mpoy C; Guo S; Laforest R; Salter A; Russell TD; Shifren A; Combadiere C; Lavine KJ; Kreisel D; Humphreys BD; Rogers BE; Gierada DS; Byers DE; Gropler RJ; Chen DL; Atkinson JJ; Liu Y
Am J Respir Crit Care Med; 2021 Jan; 203(1):78-89. PubMed ID: 32673071
[No Abstract] [Full Text] [Related]
17. CCR2 Positron Emission Tomography for the Assessment of Abdominal Aortic Aneurysm Inflammation and Rupture Prediction.
English SJ; Sastriques SE; Detering L; Sultan D; Luehmann H; Arif B; Heo GS; Zhang X; Laforest R; Zheng J; Lin CY; Gropler RJ; Liu Y
Circ Cardiovasc Imaging; 2020 Mar; 13(3):e009889. PubMed ID: 32164451
[TBL] [Abstract][Full Text] [Related]
18. Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling.
Knight JC; Torres JB; Goldin R; Mosley M; Dias GM; Bravo LC; Kersemans V; Allen PD; Mukherjee S; Smart S; Cornelissen B
J Nucl Med; 2020 Jul; 61(7):1006-1013. PubMed ID: 31862800
[TBL] [Abstract][Full Text] [Related]
19. Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody.
Torres JB; Knight JC; Mosley MJ; Kersemans V; Koustoulidou S; Allen D; Kinchesh P; Smart S; Cornelissen B
Mol Imaging Biol; 2018 Apr; 20(2):292-299. PubMed ID: 28842811
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical FAP Expression Reflects
Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
